Adelaide, Australia – Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed PhD and NHMRC Fellow Patrick Hughes as R&D Manager Immunobiology.
Agilex Biolabs specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments.
Agilex Biolabs, the only FDA-inspected lab of its type in the region, is located in Adelaide, South Australia in a science and biotech specialist hub.
Agilex Biolabs CEO Jason Valentine said:
“We are extremely pleased to have Patrick with his impressive scientific experience join our fast-growing bioanalytics company. He is an outstanding specialist research scientist who has been published in leading journals like JAMA, has authored and co-authored 29 papers, and is a senior lecturer at the Adelaide University Medical School.
“Agilex Biolabs stands out from the rest because of its talented team as well as state-of-the-art customized lab technology. Patrick is a perfect example of the caliber of talent we are consistently attracting to deliver world-class services for our clients.”
“By combining specialised expertise, technological innovation and a 20-year track record, we have supported hundreds of preclinical and clinical trials around the world.”
“Patrick joins us as we expand our labs by more than 30% to accommodate biotech demand from APAC and the USA.” Watch the Virtual Labs Tour Video Here
More than 38% of Agilex Biolabs’ biotech clients already come from the APAC region – primarily from China and South Korea.
APAC clients are particularly attracted by Agilex Biolabs’ FDA-inspected status, and the more than 40% rebate on clinical trial spend that applies in Australia.
Agilex Biolabs specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gurolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser).
Agilex also offers pharmacodynamics servicesthat include immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, including:
- Receptor occupancy
· Cytokine release assays (whole blood or PBMC stimulation assays) and
- PBMC assays and cellular mechanism of action assays (eg: ADCC)
The FDA-inspected facilities have more than 65 dedicated laboratory staff, and annually support more than 80 clinical trials. This year they will analyse more than 60,000 samples for pharma/biotechs from US, Europe and APAC.
“Our world-class bioanalytical facilities have OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition.”